6-deoxy-6-amino chitosan: a preventative treatment in the tomato/Botrytis cinerea pathosystem.

6-deoxy-6-amino chitosan (aminochitosan) is a water-soluble chitosan derivative with an additional amine group at the C-6 position. This modification has improved aqueous solubility, in vitro antifungal activity and is hypothesized to have enhanced in vivo antifungal activity compared to native chitosan. Gray mold disease in tomatoes is caused by the fungus, Botrytis cinerea, and poses a severe threat both pre- and post-harvest. To investigate the optimal concentration of aminochitosan and its lower molecular weight fractions for antifungal and priming properties in the tomato/B. cinerea pathosystem, different concentrations of aminochitosan were tested in vitro on B. cinerea growth and sporulation and in vivo as a foliar pre-treatment in tomato leaves. The leaves were monitored for photosynthetic changes using multispectral imaging and hydrogen peroxide accumulation using DAB. Despite batch-to-batch variations in aminochitosan, it displayed significantly greater inhibition of B. cinerea in vitro than native chitosan at a minimum concentration of 1 mg/mL. A concentration-dependent increase in the in vitro antifungal activities was observed for radial growth, sporulation, and germination with maximum in vitro inhibition for all the biopolymer batches and lower MW fractions at 2.5 and 5 mg/mL, respectively. However, the inhibition threshold for aminochitosan was identified as 1 mg/mL for spores germinating in vivo, compared to the 2.5 mg/mL threshold in vitro. The pre-treatment of leaves displayed efficacy in priming direct and systemic resistance to B. cinerea infection at 4, 6 and 30 days post-inoculation by maintaining elevated Fv/Fm activity and chlorophyll content due to a stronger and more rapid elicitation of the defense systems at earlier time points. Moreover, these defense systems appear to be ROS-independent at higher concentrations (1 and 2.5 mg/mL). In addition, aminochitosan accumulates in the cell membrane and therefore acts to increase the membrane permeability of cells after foliar spray. These observations corroborate the notion that aminochitosan biopolymers can exert their effects through both direct mechanisms of action and indirect immunostimulatory mechanisms. The contrast between in vitro and in vivo efficacy highlights the bimodal mechanisms of action of aminochitosan and the advantageous role of primed plant defense systems.

Galenia africana plant extract exhibits cytotoxicity in breast cancer cells by inducing multiple programmed cell death pathways.

Globally, breast cancer is the most common malignancy in women and the second most common cause of cancer-related death among women. There is therefore a need to identify more efficacious therapies for this neoplasm. Galenia africana (Kraalbos) is a perennial shrub found in Southern Africa and is used by the indigenous people to treat various ailments. There has therefore been much interest to establish the scientific basis for the medicinal properties of Kraalbos. This study aimed to investigate and characterise the anti-cancer activity of an ethanolic extract of Kraalbos leaves, KB2, against oestrogen receptor positive (MCF-7) and triple negative (MDA-MB-231) breast cancer cells. LC-MS/MS analyses identified the phytochemicals 7'-hydroxyflavanone, 5',7'-dihydroxyflavanone, 2',4'-dihydroxydihydrochalcone and 2',4'-dihydroxychalcone in KB2. KB2 exhibited an IC50 of 114 µg/ml and 130.5 µg/ml in MCF-7 and MDA-MB-231 cells respectively, selectively inhibited their long-term survival and reduced their migration which correlated with a decrease in EMT markers. It induced oxidative stress (ROS), DNA damage (increased levels of γ-H2AX), and triggered cell cycle arrests in MCF-7 and MDA-MB-231 cells. Importantly, KB2 activated intrinsic (cleaved caspase 9) and extrinsic (cleaved caspase 8) apoptosis, necroptosis (p-RIP3 and the downstream target of the necrosome, pMLKL) and autophagy (LC3II). Co-treatment of the breast cancer cells with KB2 and the autophagy inhibitor bafilomycin A1 resulted in a significant increase in cell viability which suggests that KB2 induced autophagy is a cell death mechanism.

In vitro and in vivo toxicity evaluation of non-neuroleptic phenothiazines, antitubercular drug candidates.

The phenothiazine-derived antipsychotic drugs, such as chlorpromazine and thioridazine, are bactericidal against drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis, but produce undesirable side effects at clinically relevant doses. We have previously modified four novel phenothiazines and maintained their antimycobacterial activity. This study evaluated the pharmacological and toxicity profiles of these novel non-neuroleptic phenothiazines, PTZ3, PTZ4, PTZ31 and PTZ32, for their metabolic stability, kinetic solubility and potential cytotoxic effects in vitro. To further support the safet use of these drug candidates, the in vivo pharmacological and toxicity profiles were assessed in C57BL/6 mice via single or repeated oral gavage. In acute toxicity studies, all four modified phenothiazines showed favourable safety in mice. When treated daily with 100 mg/kg of PTZ3 and PTZ4 for 2 weeks, mice displayed no signs of toxicity. Alternatively, treatment with PTZ31 resulted in 20% mortality with no toxicity evident in biochemical or histological analysis, while exposure to PTZ32 resulted in a 45% survival with increased serum concentrations of uric acid and alkaline phosphatase. The combined non-neuroleptic and antimycobacterial effects of the novel phenothiazines PTZ3, PTZ4, PTZ31 and PTZ32 demonstrated favourable pharmacological and toxicity profiles in this study, highlight the potential of these compounds as suitable anti-tuberculosis drug candidates.

Expedient synthesis and properties of 6-deoxy-6-amino chitosan.

Chitin and chitosan play an important role in the context of a biorefinery where waste is converted into useful products. The introduction of an amine at the C-6 position of chitosan has led to the synthesis of a water-soluble chitosan derivative, 6-deoxy-6-amino chitosan. However, all known synthetic methods for the synthesis of 6-deoxy-6-amino chitosan have some limitations, which acts as impediments to the scale up process and ultimately exploitation. The solubility of the polymer in water is advantageous and opens many different avenues of application. A shorter and scalable synthetic pathway was sought due to the prior use of hazardous solvents and the generation of large quantities of waste. To aid the modification of chitin and chitosan, a model study on the glucosamine monomer was utilised. An innovative synthetic means of introducing an amine at C-6 position of the biopolymer was achieved. Ultimately, this expedient synthesis of 6-deoxy-6-amino chitosan resulted in a much-improved yield and quality of 6-deoxy-6-amino chitin and chitosan. Additionally the synthesis of an alkylamino derivative was also considered. The antimicrobial properties of the improved synthetic chitosan derivatives was evaluated and compared against material prepared from prior synthetic routes.

Chitosan derivatives as important biorefinery intermediates. Quaternary tetraalkylammonium chitosan derivatives utilized in anion exchange chromatography for perchlorate removal.

There has recently been great interest in the valorization of biomass waste in the context of the biorefinery. The biopolymer chitosan, derived from chitin, is present in large quantities of crustacean waste. This biomass can be converted into value-added products with applications in energy, fuel, chemicals and materials manufacturing. The many reported applications of this polymer can be attributed to its unique properties, such as biocompatibility, chemical versatility, biodegradability and low toxicity. Cost effective water filters which decontaminate water by removal of specific impurities and microbes are in great demand. To address this need, the development of ion exchange resins using environmentally friendly, renewable materials such as biopolymers as solid supports was evaluated. The identification and remediation of perchlorate contaminated water using an easy, inexpensive method has come under the spotlight recently. Similarly, the use of a low cost perchlorate selective solid phase extraction (SPE) cartridge that can be rapidly employed in the field is desirable. Chitosan based SPE coupled with colorimetric analytical methods showed promise as a renewable anion exchange support for perchlorate analysis or removal. The polymers displayed perchlorate retention comparable to the commercial standard whereby the quaternized iron loaded polymer TMC-Fe(III) displayed the best activity.

Improved synthesis of the super antioxidant, ergothioneine, and its biosynthetic pathway intermediates.

Ergothioneine and mycothiol are low molecular mass redox protective thiols present in actinomycetes, in particular mycobacteria. We report the improved chemical synthesis of ergothioneine (ESH) and biosynthetic pathway intermediates using either histidine or ESH as the starting material. The detailed mechanism of ESH biosynthesis has not yet been completely elucidated and substrates for enzymes in the pathway will provide valuable tools to aid this study. Particularly interesting is the PLP dependent ß-lyase, EgtE, of mycobacteria, having the capability of cleaving the substrate, S-(ß-amino-ß-carboxyethyl)ergothioneine sulfoxide, to provide ESH. A synthetic route toward ESH pathway intermediates also allowed the preparation of stable isotopically labelled hercynine-d3 which was enzymatically transformed into ESH-d3. The deuterated ergothioneine biosynthetic pathway metabolites are valuable tools for future studies.

Novel non-neuroleptic phenothiazines inhibit Mycobacterium tuberculosis replication.

OBJECTIVES: Phenothiazines are a commercially available class of psychotropic drugs known to show antituberculosis activity. At clinically relevant bactericidal doses, however, the psychotropic drugs produce undesirable side effects in addition to their neuroleptic properties. This study aimed to evaluate rationally designed novel phenothiazines as antimycobacterial drug candidates. METHODS: Remodelling of psychotropic drugs by substitution of characteristic N-alkylamine side chains, important for CNS activity, with N-alkylsulphonates gave novel drug candidates, which were then tested for post-synaptic receptor binding affinity in a radioligand displacement assay. The bactericidal activities were screened using green fluorescent protein (GFP) microplate assays, and the efficacy of intracellular bacillus killing was evaluated by cfu enumeration. RESULTS: Of the four selected phenothiazine derivatives (PTZ3, PTZ4, PTZ31 and PTZ32) tested, PTZ31 displayed marginal serotonergic activity. The remaining three derivatives did not exhibit dopamine or serotonin receptor binding activity. In vitro results showed significant growth inhibition of virulent Mycobacterium tuberculosis with MICs of 12.5-25 mg/L. None of the phenothiazine derivatives displayed cytotoxicity in infected primary bone marrow-derived macrophages. Moreover, the phenothiazines showed significant antimycobacterial activity of between 40% and 60% against intracellular (ex vivo) M. tuberculosis. CONCLUSIONS: We demonstrate that structural modification of the phenothiazine core is possible in a manner that does not affect the ability of the phenothiazine derivatives to inhibit M. tuberculosis, but that abolishes undesirable dopamine and serotonin receptor binding.

Hydroformylation of 1-octene using low-generation Rh(I) metallodendritic catalysts based on a tris-2-(2-pyridyliminoethyl)amine scaffold.

The synthesis and characterization of low-generation pyridylimine Rh(I) metallodendrimers is described. These metallodendrimers were obtained via a Schiff base condensation of tris-2-(aminoethyl)amine with 2-pyridinecarboxaldehyde to afford the tris-2-(2-pyridylimine ethyl) amine ligand (1). Subsequent complexation reactions with [RhCl(CO)(2)](2) and [RhCl(COD)](2) yielded the corresponding metal-containing dendrimers containing -RhCl(CO) and -Rh(COD) moieties on the periphery. These new rhodium metallodendrimers (2 and 3) and their precursor ligand (1) are thermally stable and have been characterized using (1)H NMR, (13)C NMR, (31)P NMR, FT-IR spectroscopy, elemental analysis as well as mass spectrometry. The Rh(I) metallodendrimers are highly active and chemo- and regioselective in the hydroformylation of 1-octene. Aldehydes were favoured at moderate to high temperatures (95 °C and 75 °C) and pressure (30 bars), while more iso-octenes were formed at low temperature (55 °C) and pressures (5 and 10 bars). The mononuclear analogues (5 and 6) also produced more aldehydes (albeit showing catalyst decomposition at 95 °C and 75 °C, 30 bars) and these aldehydes were mostly branched.

An enzyme-initiated Smiles rearrangement enables the development of an assay of MshB, the GlcNAc-Ins deacetylase of mycothiol biosynthesis.

MshB is the N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-D-glucopyranoside (GlcNAc-Ins) deacetylase active as one of the enzymes involved in the biosynthesis of mycothiol (MSH), a protective low molecular weight thiol present only in Mycobacterium tuberculosis and other actinomycetes. In this study, structural analogues of GlcNAc-Ins in which the inosityl moiety is replaced by a chromophore were synthesized and evaluated as alternate substrates of MshB, with the goal of identifying a compound that would be useful in high-throughput assays of the enzyme. In an unexpected and surprising finding one of the GlcNAc-Ins analogues is shown to undergo a Smiles rearrangement upon MshB-mediated deacetylation, uncovering a free thiol group. We demonstrate that this chemistry can be exploited for the development of the first continuous assay of MshB activity based on the detection of thiol formation by DTNB (Ellman's reagent); such an assay should be ideally suited for the identification of MshB inhibitors by means of high-throughput screens in microplates.

Inhibition of mammalian ribonucleases by endogenous adenosine dinucleotides.

The most potent low molecular weight inhibitors of pancreatic RNase superfamily enzymes reported to date are synthetic derivatives of adenosine 5(')-pyrophosphate. Here we have investigated the effects of six natural nucleotides that also incorporate this moiety (NADP(+), NADPH, ATP, Ap(3)A, Ap(4)A, and Ap(5)A) on the activities of RNase A and two of its homologues, eosinophil-derived neurotoxin and angiogenin. With eosinophil-derived neurotoxin and angiogenin, Ap(5)A is comparable to the tightest binding inhibitors identified previously (K(i) values at pH 5.9 are 370 nM and 100 microM, respectively); it ranks among the strongest small antagonists of RNase A as well (K(i)=230 nM). The K(i) for NADPH with angiogenin is similar to that of Ap(5)A. These findings suggest that Ap(5)A and NADPH may serve as useful new leads for inhibitor design. Examination of inhibition under physiological conditions indicates that NADPH, ATP, and Ap(5)A may suppress intracellular RNase activity significantly in vivo.